Study: NCT00727441

Adverse event: Chills
Serious: no
Organ System: General disorders
Notes: and administration site conditions
Frequency: 5 affected / 29 at risk

Adverse event: Fatigue
Serious: no
Organ System: General disorders
Notes: and administration site conditions
Frequency: 11 affected / 29 at risk

Adverse event: Pyrexia
Serious: no
Organ System: General disorders
Notes: and administration site conditions
Frequency: 7 affected / 29 at risk

Adverse event: White blood cell count decreased
Serious: no
Organ System: Investigations
Frequency: 2 affected / 29 at risk

Adverse event: Myalgia
Serious: no
Organ System: Musculoskeletal and connective tissue disorders
Frequency: 4 affected / 29 at risk

Adverse event: Blister, vaccine site
Serious: no
Organ System: Skin and subcutaneous tissue disorders
Frequency: 4 affected / 29 at risk

Adverse event: Skin hyperpigmentation, vaccine site
Serious: no
Organ System: Skin and subcutaneous tissue disorders
Frequency: 7 affected / 29 at risk

Adverse event: Erythema, vaccine site
Serious: no
Organ System: Skin and subcutaneous tissue disorders
Frequency: 29 affected / 29 at risk

Adverse event: Induration, vaccine site
Serious: no
Organ System: Skin and subcutaneous tissue disorders
Frequency: 29 affected / 29 at risk

Adverse event: Pruritus, vaccine site
Serious: no
Organ System: Skin and subcutaneous tissue disorders
Frequency: 24 affected / 29 at risk

Adverse event: Tenderness, vaccine site
Serious: no
Organ System: Skin and subcutaneous tissue disorders
Frequency: 23 affected / 29 at risk

Adverse event: Urticaria
Serious: no
Organ System: Skin and subcutaneous tissue disorders
Frequency: 4 affected / 29 at risk

Adverse event: Vaccine site flare
Serious: no
Organ System: Skin and subcutaneous tissue disorders
Frequency: 5 affected / 29 at risk

Adverse event: Warmth, vaccine site
Serious: no
Organ System: Skin and subcutaneous tissue disorders
Frequency: 15 affected / 29 at risk

Adverse event: Nausea
Serious: no
Organ System: Gastrointestinal disorders
Frequency: 9 affected / 28 at risk

Adverse event: Fatigue
Serious: no
Organ System: General disorders
Notes: and administration site conditions
Frequency: 7 affected / 28 at risk

Adverse event: Pyrexia
Serious: no
Organ System: General disorders
Notes: and administration site conditions
Frequency: 3 affected / 28 at risk

Adverse event: Lymphocyte count decreased
Serious: no
Organ System: Investigations
Frequency: 6 affected / 28 at risk

Adverse event: White blood cell count decreased
Serious: no
Organ System: Investigations
Frequency: 1 affected / 28 at risk

Adverse event: Blister, vaccine site
Serious: no
Organ System: Skin and subcutaneous tissue disorders
Frequency: 3 affected / 28 at risk

Adverse event: Skin hyperpigmentation, vaccine site
Serious: no
Organ System: Skin and subcutaneous tissue disorders
Frequency: 5 affected / 28 at risk

Adverse event: Erythema, vaccine site
Serious: no
Organ System: Skin and subcutaneous tissue disorders
Frequency: 28 affected / 28 at risk

Adverse event: Induration, vaccine site
Serious: no
Organ System: Skin and subcutaneous tissue disorders
Frequency: 26 affected / 28 at risk

Adverse event: Pruritus, vaccine site
Serious: no
Organ System: Skin and subcutaneous tissue disorders
Frequency: 23 affected / 28 at risk

Adverse event: Tenderness, vaccine site
Serious: no
Organ System: Skin and subcutaneous tissue disorders
Frequency: 18 affected / 28 at risk

Adverse event: Urticaria
Serious: no
Organ System: Skin and subcutaneous tissue disorders
Frequency: 3 affected / 28 at risk

Adverse event: Warmth, vaccine site
Serious: no
Organ System: Skin and subcutaneous tissue disorders
Frequency: 17 affected / 28 at risk

Adverse event: Nausea
Serious: no
Organ System: Gastrointestinal disorders
Frequency: 7 affected / 30 at risk

Adverse event: Chills
Serious: no
Organ System: General disorders
Notes: and administration site conditions
Frequency: 5 affected / 30 at risk

Adverse event: Fatigue
Serious: no
Organ System: General disorders
Notes: and administration site conditions
Frequency: 9 affected / 30 at risk

Adverse event: Pyrexia
Serious: no
Organ System: General disorders
Notes: and administration site conditions
Frequency: 4 affected / 30 at risk

Adverse event: Lymphocyte count decreased
Serious: no
Organ System: Investigations
Frequency: 11 affected / 30 at risk

Adverse event: White blood cell count decreased
Serious: no
Organ System: Investigations
Frequency: 4 affected / 30 at risk

Adverse event: Myalgia
Serious: no
Organ System: Musculoskeletal and connective tissue disorders
Frequency: 2 affected / 30 at risk

Adverse event: Skin hyperpigmentation, vaccine site
Serious: no
Organ System: Skin and subcutaneous tissue disorders
Frequency: 3 affected / 30 at risk

Adverse event: Erythema, vaccine site
Serious: no
Organ System: Skin and subcutaneous tissue disorders
Frequency: 30 affected / 30 at risk

Adverse event: Induration, vaccine site
Serious: no
Organ System: Skin and subcutaneous tissue disorders
Frequency: 30 affected / 30 at risk

Adverse event: Pruritus, vaccine site
Serious: no
Organ System: Skin and subcutaneous tissue disorders
Frequency: 24 affected / 30 at risk

Adverse event: Tenderness, vaccine site
Serious: no
Organ System: Skin and subcutaneous tissue disorders
Frequency: 19 affected / 30 at risk

Adverse event: Warmth, vaccine site
Serious: no
Organ System: Skin and subcutaneous tissue disorders
Frequency: 17 affected / 30 at risk